<p>Mice were immunized and challenged as in Fig. 3. Five days after challenge, immunized (SrtA/CTB) and PBS control mice were euthanized and NALT cell suspensions were stained with antibodies for surface markers (CD4, CD3, DX5, and γδ TCR) as needed followed by intracellular staining with PE-IL-17 and analyzed by FACS. (<i>A</i>) IL-17<sup>+</sup> γδ TCR<sup>+</sup> (γδ T) cells. (<i>B</i>) IL-17<sup>+</sup> DX5<sup>+</sup> CD3<sup>+</sup> (NKT) cells. (<i>C</i>) IL-17<sup>+</sup> DX5<sup>+</sup> CD3<sup>–</sup> (NK) cells. (<i>D</i>) IL-17<sup>+</sup> CD3<sup>–</sup> CD4<sup>–</sup> DX5<sup>–</sup> (ILC3) cells. (<i>E</i>) IL-17<sup>+</sup> CD3<sup>+</sup> CD4<sup>+</sup> CD44<sup>+</sup> (memory Th17) cells. Data are means ± SEM of three ...
<p>At day 4 after the second treatment, the splenocytes of treated mice were prepared for intracellu...
<p>WT, TLR2<sup>-/-</sup>, TLR9<sup>-/-</sup>, and TLR2/9<sup>-/-</sup> mice were exposed to SR 3 ti...
<p>A. Mice defective in IFN-γ, IL-4 or IL-17A receptor were immunized as described, then challenged ...
<p>(<i>A</i>) C57B/6 mice were immunized with SrtA/CTB three times and euthanized 10 days later. Sin...
<p>BALB/c mice (n = 5 on days 1 and3, n = 10 on day 7) were passively immunized (IP) with 2A3 or iso...
<p>Single cell suspensions of spleen and lung mononuclear cells of WT, ICOS-KO and ICOS-YF mice were...
<p><b>A</b>. EAN mice were sacrificed at nadir of EAN (day 28 p.i.) and CE infiltrating cells were a...
<p>A) Splenocytes were stimulated and rested, and IL-17 production by CD8 γδ and DN γδ T cells was m...
<p>C57BL/6 mice (black bars) and IL-22<sup>−/−</sup> (white bars) mice were infected with approx. 10...
Single-cell suspensions were stimulated with PMA plus ionomycin with Golgi Plug for 4 h, stained, an...
<p>Four weeks after completion of immunization a separate group of 3 naïve mice were left unchalleng...
<p>WT and CD38 KO mice male mice were immunized with col II-CFA. For intracellular cytokine staining...
<p>A-B) Splenocytes from 10-12 week old Egr3 WT and Egr3 TG mice were stimulated for 2 days with sol...
(B) CD4 T cells from OT-II mice were differentiated into Th1, Th2, and Th17 lineages. On day 5 of cu...
<p>BALB/c mice were repeatedly injected with 50 µL of pyrogen-free saline (□) or 10 μg (protein) of ...
<p>At day 4 after the second treatment, the splenocytes of treated mice were prepared for intracellu...
<p>WT, TLR2<sup>-/-</sup>, TLR9<sup>-/-</sup>, and TLR2/9<sup>-/-</sup> mice were exposed to SR 3 ti...
<p>A. Mice defective in IFN-γ, IL-4 or IL-17A receptor were immunized as described, then challenged ...
<p>(<i>A</i>) C57B/6 mice were immunized with SrtA/CTB three times and euthanized 10 days later. Sin...
<p>BALB/c mice (n = 5 on days 1 and3, n = 10 on day 7) were passively immunized (IP) with 2A3 or iso...
<p>Single cell suspensions of spleen and lung mononuclear cells of WT, ICOS-KO and ICOS-YF mice were...
<p><b>A</b>. EAN mice were sacrificed at nadir of EAN (day 28 p.i.) and CE infiltrating cells were a...
<p>A) Splenocytes were stimulated and rested, and IL-17 production by CD8 γδ and DN γδ T cells was m...
<p>C57BL/6 mice (black bars) and IL-22<sup>−/−</sup> (white bars) mice were infected with approx. 10...
Single-cell suspensions were stimulated with PMA plus ionomycin with Golgi Plug for 4 h, stained, an...
<p>Four weeks after completion of immunization a separate group of 3 naïve mice were left unchalleng...
<p>WT and CD38 KO mice male mice were immunized with col II-CFA. For intracellular cytokine staining...
<p>A-B) Splenocytes from 10-12 week old Egr3 WT and Egr3 TG mice were stimulated for 2 days with sol...
(B) CD4 T cells from OT-II mice were differentiated into Th1, Th2, and Th17 lineages. On day 5 of cu...
<p>BALB/c mice were repeatedly injected with 50 µL of pyrogen-free saline (□) or 10 μg (protein) of ...
<p>At day 4 after the second treatment, the splenocytes of treated mice were prepared for intracellu...
<p>WT, TLR2<sup>-/-</sup>, TLR9<sup>-/-</sup>, and TLR2/9<sup>-/-</sup> mice were exposed to SR 3 ti...
<p>A. Mice defective in IFN-γ, IL-4 or IL-17A receptor were immunized as described, then challenged ...